Indian Immunologicals Ltd (IIL) is a leading biological company in the country. On Monday, November 2, 2015, IIL inaugurated its new bovine serum manufacturing facility in New Zealand.
A statement by IIL said, "Pristine Biologicals (NZ) Ltd (PBL), a wholly owned subsidiary of IIL, was inaugurated by National Dairy Development Board (NDDB) chairman T. Nanda Kumar, in the presence of New Zealander's Food Safety Development and Primary Industries Minister Jo Goodhew, IIL MD and PBL director K. V. Balasubramaniam."
IIL established PBL in 2014 to gain control over the supplies of a key ingredient used in vaccine manufacture. Serum from New Zealand is highly regarded as the country is free from several diseases listed by the World Organization for Animal Health (OIE). This new plant can manufacture up to 300 tonne of serum.
IIL's deputy managing director Anand Kumar said, "With this new facility IIL not only becomes self sufficient for a key ingredient but also has spare capacity to provide it to other quality conscious manufacturers as well."